Serial Number:
86958426
Mark:
APOPHARMA USA
Status:
Abandoned-No Statement of Use filed
Status Date:
07-13-2020
Filing Date:
Registration Number:
N/A
Registration Date:
N/A
Pharmaceutical preparations, namely, prescription drugs for the treatment of multiple myeloma by slowing the growth of cancer cells, prescription drugs for the treatment of multiple myeloma by stopping the growth of cancer cells, prescription drugs for palliative treatment of patients with multiple myeloma, and prescription drugs for use as an iron chelator for the treatment of patients with transfusion iron overload due to thalassemia syndromes, prescription drugs for the treatment of iron-associated neurodegenerative conditions, namely, Parkinson's disease and neurodegeneration with brain iron accumulation, in particular, pantothenate kinase-associated neurodegeneration
Mark Description:
The mark consists of the word "APOPHARMA" with "USA" underneath and a swoosh design at the end.
Class:
Pharmaceutical and veterinary preparations
Type of Mark:
Trademark
Published for Opposition Date:
04-11-2017
Owner:
Mark Drawing Status:
Design plus Words, Letters, and/or Numbers
Abandon Date:
07-13-2020
Business Name:
NIXON & VANDERHYE P.C.
Correspondent Name:
